% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Cervenka:144812,
author = {I. Cervenka and M. Al Rahmoun and Y. Mahamat-Saleh and A.
Fournier and M. C. Boutron-Ruault and G. Severi and S. Caini
and D. Palli and R. Ghiasvand and M. B. Veierod and E.
Botteri and A. Tjønneland and A. Olsen and R. T.
Fortner$^*$ and R. Kaaks$^*$ and M. B. Schulze and S. Panico
and A. Trichopoulou and C. Dessinioti and K. Niforou and S.
Sieri and R. Tumino and C. Sacerdote and B.
Bueno-de-Mesquita and T. M. Sandanger and S. Colorado-Yohar
and M. J. Sánchez and L. Gil Majuelo and L. Lujan-Barroso
and E. Ardanaz and S. Merino and K. Isaksson and S. Butt and
I. Ljuslinder and M. Jansson and R. C. Travis and K. T. Khaw
and E. Weiderpass and L. Dossus and S. Rinaldi and M.
Kvaskoff},
title = {{E}xogenous {H}ormone {U}se and {C}utaneous {M}elanoma
{R}isk in {W}omen: {T}he {E}uropean {P}rospective
{I}nvestigation {I}nto {C}ancer and {N}utrition.},
journal = {International journal of cancer},
volume = {146},
number = {12},
issn = {1097-0215},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2019-02237},
pages = {3267-3280},
year = {2020},
note = {2020 Jun 15;146(12):3267-3280},
abstract = {Evidence suggests an influence of sex hormones on cutaneous
melanoma risk, but epidemiologic findings are conflicting.
We examined the associations between use of oral
contraceptives (OCs) and menopausal hormone therapy (MHT)
and melanoma risk in women participating in the European
Prospective Investigation into Cancer and Nutrition (EPIC).
EPIC is a prospective cohort study initiated in 1992 in 10
European countries. Information on exogenous hormone use at
baseline was derived from country-specific self-administered
questionnaires. We used Cox proportional hazards regression
models to calculate hazard ratios (HRs) and $95\%$
confidence intervals (CIs). Over 1992-2015, 1,696 melanoma
cases were identified among 334,483 women, whereof 770 cases
among 134,758 postmenopausal women. There was a positive,
borderline-significant association between OC use and
melanoma risk (HR=1.12, $95\%$ CI=1.00-1.26), with no
detected heterogeneity across countries (Phomogeneity
=0.42). This risk increased linearly with duration of use
(Ptrend =0.01). Among postmenopausal women, ever use of MHT
was associated with a non-significant increase in melanoma
risk overall (HR=1.14, $95\%$ CI=0.97-1.43), which was
heterogeneous across countries (Phomogeneity =0.05). Our
findings do not support a strong and direct association
between exogenous hormone use and melanoma risk. In order to
better understand these relations, further research should
be performed using prospectively collected data including
detailed information on types of hormone, and on sun
exposure, which may act as an important confounder or effect
modifier on these relations. This article is protected by
copyright. All rights reserved.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31506954},
doi = {10.1002/ijc.32674},
url = {https://inrepo02.dkfz.de/record/144812},
}